Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines

Suzanne Ostrand-Rosenberg; Beth A. Pulaski; Todd D. Armstrong; Virginia K. Clements

doi:10.1007/978-1-4615-5357-1_42

Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines

Suzanne Ostrand-Rosenberg, Beth A. Pulaski, Todd D. Armstrong, Virginia K. Clements

School of Medicine

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	259-264
Number of pages	6
Journal	Advances in experimental medicine and biology
Volume	451
DOIs	https://doi.org/10.1007/978-1-4615-5357-1_42
State	Published - 1998

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1007/978-1-4615-5357-1_42

Cite this

@article{0f477c669daf436995bc0e82ffe43693,

title = "Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines",

author = "Suzanne Ostrand-Rosenberg and Pulaski, {Beth A.} and Armstrong, {Todd D.} and Clements, {Virginia K.}",

year = "1998",

doi = "10.1007/978-1-4615-5357-1_42",

language = "English (US)",

volume = "451",

pages = "259--264",

journal = "Advances in experimental medicine and biology",

issn = "0065-2598",

publisher = "Springer New York",

}

TY - JOUR

T1 - Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines

AU - Ostrand-Rosenberg, Suzanne

AU - Pulaski, Beth A.

AU - Armstrong, Todd D.

AU - Clements, Virginia K.

PY - 1998

Y1 - 1998

UR - http://www.scopus.com/inward/record.url?scp=0031724858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031724858&partnerID=8YFLogxK

U2 - 10.1007/978-1-4615-5357-1_42

DO - 10.1007/978-1-4615-5357-1_42

M3 - Article

C2 - 10026883

AN - SCOPUS:0031724858

SN - 0065-2598

VL - 451

SP - 259

EP - 264

JO - Advances in experimental medicine and biology

JF - Advances in experimental medicine and biology

ER -

Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this